Showing results (1781-1790 of 5,535) with videos related to
Sort By:
Pageof 554
Inflammatory Bowel Diseases|March 11, 2021
The Pathogenesis and Clinical Management of Stricturing Crohn DiseaseChristopher J Schmoyer, Jakob Saidman, Jaime L Bohl, et al.Inflammatory Bowel Diseases|October 26, 2018
Targeted Analysis of Serum Proteins Encoded at Known Inflammatory Bowel Disease Risk LociKimi Drobin, Ghazaleh Assadi, Mun-Gwan Hong, et al.Inflammatory Bowel Diseases|November 1, 2018
How Can We Improve to Keep Our Patients Out of the Hospital?Taylor Schmidt, Linda A FeaginsInflammatory Bowel Diseases|June 4, 2008
Urinary neopterin is a valuable tool in monitoring Crohn's disease activityS Nancey, A Perret-Liaudet, D Moussata, et al.Inflammatory Bowel Diseases|June 5, 2008
Leukocyte adhesion molecules in animal models of inflammatory bowel diseaseJesús Rivera-Nieves, Gezahegn Gorfu, Klaus LeyInflammatory Bowel Diseases|February 25, 2014
The effects of infliximab or adalimumab on vascular endothelial growth factor and angiopoietin 1 angiogenic factor levels in inflammatory bowel disease: serial observations in 37 patientsAlicia Algaba, Pablo M Linares, M Encarnación Fernández-Contreras, et al.Inflammatory Bowel Diseases|July 18, 2019
Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based StudyMohammed Zaahid Sheriff, Emad Mansoor, Jay Luther, et al.Inflammatory Bowel Diseases|July 14, 2019
Patients Perception of Risks and Benefits of Biologic TherapyKara Mari De FeliceInflammatory Bowel Diseases|March 24, 2010
4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel diseaseLeo R Fitzpatrick, Ludwig Deml, Claudia Hofmann, et al.Inflammatory Bowel Diseases|March 24, 2010
Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in miceSeung Won Kim, Hee Man Kim, Kyoung Min Yang, et al.Pageof 554